✦ LIBER ✦

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

✍ Scribed by Hany Onsy Habashy; Desmond G. Powe; Cindy M. Staka; Emad A. Rakha; Graham Ball; Andrew R. Green; Mohammed Aleskandarany; E. Claire Paish; R. Douglas Macmillan; Robert I. Nicholson; Ian O. Ellis; Julia M. W. Gee

Book ID: 106378212
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 575 KB
Volume: 119
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0345-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypoxia inducible factor-1α is a prognos

Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response

✍ Åsa Kronblad; Karin Jirström; Lisa Rydén; Bo Nordenskjöld; Göran Landberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 765 KB

## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting

Expression of tumor-associated 90k-antig

Expression of tumor-associated 90k-antigen in human breast cancer: No correlation with prognosis and response to first-line therapy with tamoxifen

✍ John A. Foekens; Jan G. M. Klun; Clara Natoli; Wim L. J. Van Putten; Pia Di Stef 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 614 KB

It has been shown that a 90-kDa protein (90K). with an as yet unknown function, is expressed in the majority of human breast-cancer tissues. In addition, the serum level of this 90K antigen is elevated in a certain proportion of breast-cancer patients, and high serum levels are associated with a poo